Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway
Authors
Keywords
-
Journal
JOURNAL OF LIPID RESEARCH
Volume 58, Issue 1, Pages 60-71
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2016-11-22
DOI
10.1194/jlr.m072421
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elucidating the chemical structure of native 1-deoxysphingosine
- (2016) Regula Steiner et al. JOURNAL OF LIPID RESEARCH
- Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
- (2015) M. F. Dohrn et al. EUROPEAN JOURNAL OF NEUROLOGY
- Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy
- (2015) Rita Kramer et al. FASEB JOURNAL
- Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
- (2015) Alaa Othman et al. Journal of Clinical Lipidology
- Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
- (2015) D. Lee Gorden et al. JOURNAL OF LIPID RESEARCH
- Lowering Plasma 1-Deoxysphingolipids Improves Neuropathy in Diabetic Rats
- (2014) Alaa Othman et al. DIABETES
- Inhibition of CYP4A Reduces Hepatic Endoplasmic Reticulum Stress and Features of Diabetes in Mice
- (2014) Edmond Changkyun Park et al. GASTROENTEROLOGY
- Deoxysphingolipids, Novel Biomarkers for Type 2 Diabetes, Are Cytotoxic for Insulin-Producing Cells
- (2013) R. A. Zuellig et al. DIABETES
- Straightforward Access to Spisulosine and 4,5-Dehydrospisulosine Stereoisomers: Probes for Profiling Ceramide Synthase Activities in Intact Cells
- (2013) José Luis Abad et al. JOURNAL OF ORGANIC CHEMISTRY
- Diabetic neuropathy: clinical manifestations and current treatments
- (2012) Brian C Callaghan et al. LANCET NEUROLOGY
- Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation
- (2011) Neha Sehgal et al. BIOCHEMICAL PHARMACOLOGY
- Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies
- (2011) P. Schöffski et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1
- (2011) Kevin Garofalo et al. JOURNAL OF CLINICAL INVESTIGATION
- CYP4F Enzymes Are Responsible for the Elimination of Fingolimod (FTY720), a Novel Treatment of Relapsing Multiple Sclerosis
- (2010) Y. Jin et al. DRUG METABOLISM AND DISPOSITION
- Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids
- (2010) Anke Penno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipidomics reveals a remarkable diversity of lipids in human plasma,
- (2010) Oswald Quehenberger et al. JOURNAL OF LIPID RESEARCH
- PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid -Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
- (2010) James P. Hardwick et al. PPAR Research
- Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
- (2009) R. D. Baird et al. MOLECULAR CANCER THERAPEUTICS
- Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases
- (2008) James P. Hardwick BIOCHEMICAL PHARMACOLOGY
- Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCζ activation
- (2008) Ana M. Sánchez et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ceramide Synthase Inhibition by Fumonisin B1Causes Accumulation of 1-Deoxysphinganine
- (2008) Nicholas C. Zitomer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now